MediPharm Labs Corp. (TSX:LABS)
0.0650
0.00 (0.00%)
At close: Mar 20, 2026
MediPharm Labs Market Cap
MediPharm Labs has a market cap or net worth of CAD 27.62 million as of March 20, 2026. Its market cap has decreased by -16.84% in one year.
Market Cap
27.62M
Enterprise Value
16.76M
Revenue
46.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since October 5, 2018, MediPharm Labs's market cap has decreased from 213.11M to 27.62M, a decrease of -87.04%. That is a compound annual growth rate of -23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 27.62M | 0.98% |
| Dec 31, 2025 | 27.35M | 10.87% |
| Dec 31, 2024 | 24.67M | -5.43% |
| Dec 29, 2023 | 26.08M | 32.06% |
| Dec 30, 2022 | 19.75M | -60.54% |
| Dec 31, 2021 | 50.06M | -39.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C21 Investments | 44.81M |
| iAnthus Capital Holdings | 34.86M |
| Rubicon Organics | 32.78M |
| Optimi Health | 28.07M |
| Greenway Greenhouse Cannabis | 23.98M |
| Voyageur Pharmaceuticals | 23.22M |
| Avicanna | 20.13M |
| 1CM Inc. | 20.02M |